Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD40 antibodies capable of blocking B-cell activation

Anti-CD40 antibodies capable of blocking B-cell activation

US Patent 7361345 · Granted Apr 22, 2008

Estimated economic value: $43,218,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antagonistic anti-human CD40 monoclonal antibodies2022
Gene constructs coding for CD40-binding activating antibodies2010
Anti-CD40 antibodies capable of blocking B-cell activation2010
Anti-CD40 antibodies capable of blocking B-cell activation2010
CD40-binding activating antibodies2009
Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies2007
Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclo2005
Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclo2005
Hydroprocessing catalyst and use thereof2005
Methods of treating autoimmune diseases with a CD86-specific immunotoxin2002
Catalyst comprising at least a hydrogenation metal component and a synthetic cla2002
Methods of blocking B-cell activation using anti-CD40 monoclonal antibodies2001